gms | German Medical Science

69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

03.06. - 06.06.2018, Münster

The current management of spinal cord cavernoma

Meeting Abstract

  • Julia Velz - Universitätspital Zürich, Klinik für Neurochirurgie, Zürich, Schweiz
  • Oliver Bozinov - Universitätspital Zürich, Klinik für Neurochirurgie, Zürich, Schweiz
  • David Bellut - Universitätspital Zürich, Klinik für Neurochirurgie, Zürich, Schweiz
  • Johannes Sarnthein - Universitätspital Zürich, Klinik für Neurochirurgie, Zürich, Schweiz
  • Luca Regli - Universitätspital Zürich, Klinik für Neurochirurgie, Zürich, Schweiz

Deutsche Gesellschaft für Neurochirurgie. 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie. Münster, 03.-06.06.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocP155

doi: 10.3205/18dgnc496, urn:nbn:de:0183-18dgnc4965

Veröffentlicht: 18. Juni 2018

© 2018 Velz et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Spinal cavernous malformations (SCM) were once thought to be rare lesions of the spinal cord. However, with the broad use of modern imaging techniques the incidence of SCM has significantly increased over the last decades.

Management of both symptomatic and especially asymptomatic SCM is therefore of growing importance. However, experience with treatment and follow-up is very limited.

Methods: We performed a single institution retrospective review of consecutive patients with SCM treated at our Department between 2006-2016 and discuss the clinical features and surgical vs. conservative outcomes. We further provide a review of the literature and discuss the best management of SCM, analyzing recent publications on SCM imaging techniques, surgical approaches and natural history.

Results: From a total number of 406 consecutive patients with cavernous malformations (CM) treated at our department between 2006 and 2016, 29 (7.1 %) had SCM. The localization was cervical in 10 (34.5 %), cervicothoracic in 3 (10.4 %) and thoracic in 16 (55.2 %) patients. In 90 % of patients (n = 26) the diagnosis was made after onset of clinical symptoms. Conservative management was performed for 8 patients, whereas 21 patients underwent surgical removal of the lesion via a posterior approach using (hemi-) laminectomy or laminoplasty.

Functional status improved in 15 patients (62. 5%) and remained unchanged in 6 patients (28.5 %) in the operative group, whereas 2 patients (25 %) improved and 6 patients (75 %) remained unchanged in the conservative group during long-term follow-up.

Conclusion: Gross-total resection is the only definitive treatment option for symptomatic SCM. Surgical extirpation of the symptomatic SCM lesion through a hemilaminectomy approach within 3 months of presentation seems to be good treatment option with an acceptable risk of complications and good long-term outcomes.

Conservative treatment should be performed in asymptomatic patients and seems to be an option as well if patients’ symptoms at diagnosis are mild and do not show progression over time.

Figure 1 [Fig. 1], Figure 2 [Fig. 2]